ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 30 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2020$85,000
-52.0%
23,353
-49.1%
0.00%
Q3 2020$177,000
+35.1%
45,853
+32.3%
0.00%
Q2 2020$131,00034,6530.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$3,3060.09%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$35,5840.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$183,2920.01%
MEITAV INVESTMENT HOUSE LTD 244,482$318,8280.01%
Psagot Value Holdings Ltd. / (Israel) 6,000$80.00%
IHT Wealth Management, LLC 26,800$36,7160.00%
Altshuler Shaham Ltd 12,478$17,0950.00%
Smith Salley Wealth Management 12,048$16,5060.00%
Ten Capital Wealth Advisors, LLC 1,000$1,3700.00%
BANK OF AMERICA CORP /DE/ 2,967$4,0650.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders